21 CFR §314.630
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
Drug products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting requirements applicable to all approved drug products, as provided in §§ 314.80 and 314.81.